Physical characterization is central to the development of small molecule pharmaceutics, but focusing on particle size can sometimes be right or wrong. Our guest speaker, Dr. Mick Hurrey of SteadyMed Therapeutics shares his experience on solid oral dosage characterization.
In this webinar, you'll learn about:
Tiene alguna pregunta o solicitud? Utilice este formulario para ponerse en contacto con nuestros especialistas.